Internal Medicine, Rheumatology · Albuquerque, NM
NPI
1366854044
Since 2014
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1 University of New Mexico, Msc 10 5550
Albuquerque, NM, 87131
Phone (505) 272-6331
Groups this clinician bills Medicare through
Medicare paid, 2024
$34K
519 services
Medicare patients, 2024
227
Average age 70
Drug cost, 2024
$3.1M
2,896 prescriptions
Company payments, 2025
$224
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ola M Azzouqah was code 99214 (office e&m - established), 252 times for 163 patients. In total Ola M Azzouqah billed 519 services in 13 codes, and Medicare paid $34K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-07-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 252 | 163 | $64.57 | $16K |
| 99215 Office E&M - Established | Office | 103 | 74 | $95.97 | $9,885 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 94 | 94 | $12.51 | $1,176 |
| 99204 Office E&M - New | Office | 34 | 34 | $96.36 | $3,276 |
| 99205 Office E&M - New | Office | 14 | 14 | $133.94 | $1,875 |
By year: 2022 $33K for 390 services; 2023 $34K for 421 services; 2024 $34K for 519 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ola M Azzouqah prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 579 prescriptions and refills. In total Ola M Azzouqah wrote 2,896 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 579 | 1,545 | 177 | $20K |
| Methotrexate Methotrexate Sodium | 373 | 961 | 122 | $9,738 |
| Prednisone Generic | 314 | 536 | 102 | $3,123 |
| Alendronate Sodium Generic | 109 | 255 | 32 | $1,009 |
| Methylprednisolone Generic | 106 | 110 | 77 | $1,066 |
| Leflunomide Generic | 102 | 270 | 31 | $5,925 |
| Amjevita(Cf) Autoinjector Adalimumab-Atto | 75 | 75 | Under 11 | $235K |
| Allopurinol Generic | 75 | 225 | 31 | $1,520 |
| Enbrel Sureclick Etanercept | 69 | 69 | Under 11 | $502K |
| Mycophenolate Mofetil Generic | 69 | 165 | 19 | $12K |
| Diclofenac Sodium Generic | 63 | 71 | 26 | $1,662 |
| Humira(Cf) Pen Adalimumab | 61 | 65 | Under 11 | $447K |
| Pilocarpine Hcl Generic | 53 | 116 | 17 | $2,686 |
| Actemra Actpen Tocilizumab | 51 | 51 | Under 11 | $217K |
| Celecoxib Generic | 48 | 88 | 13 | $2,540 |
Brand drugs: - claims; generic drugs: 2,310 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ola M Azzouqah $224 ($224 in general payments such as food, travel and fees) from 5 companies. The largest payer was UCB, Inc. with $69.1.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.